These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24113308)

  • 1. Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.
    Chui MH; Gilks CB; Cooper K; Clarke BA
    Adv Anat Pathol; 2013 Nov; 20(6):378-86. PubMed ID: 24113308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.
    Ketabi Z; Bartuma K; Bernstein I; Malander S; Grönberg H; Björck E; Holck S; Nilbert M
    Gynecol Oncol; 2011 Jun; 121(3):462-5. PubMed ID: 21388660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary.
    Vierkoetter KR; Ayabe AR; VanDrunen M; Ahn HJ; Shimizu DM; Terada KY
    Gynecol Oncol; 2014 Oct; 135(1):81-4. PubMed ID: 25093288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
    Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
    BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
    Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
    Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas.
    Clarke BA; Cooper K
    Adv Anat Pathol; 2012 Jul; 19(4):231-8. PubMed ID: 22692286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.
    Akbari MR; Zhang S; Cragun D; Lee JH; Coppola D; McLaughlin J; Risch HA; Rosen B; Shaw P; Sellers TA; Schildkraut J; Narod SA; Pal T
    Fam Cancer; 2017 Jul; 16(3):351-355. PubMed ID: 28176205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features and management of Lynch syndrome-associated ovarian cancer.
    Ran X; Jing H; Li Z
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.
    Lu FI; Gilks CB; Mulligan AM; Ryan P; Allo G; Sy K; Shaw PA; Pollett A; Clarke BA
    Int J Gynecol Pathol; 2012 Nov; 31(6):524-31. PubMed ID: 23018216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.
    Niskakoski A; Kaur S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Int J Cancer; 2013 Dec; 133(11):2596-608. PubMed ID: 23716351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).
    Zeimet AG; Mori H; Petru E; Polterauer S; Reinthaller A; Schauer C; Scholl-Firon T; Singer C; Wimmer K; Zschocke J; Marth C
    Arch Gynecol Obstet; 2017 Jul; 296(1):123-127. PubMed ID: 28510097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
    Nakonechny QB; Gilks CB
    Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.